Avecia
Avecia, a part of Nitto Denko Inc.[1], is a private biotechnology company focused on the development and manufacture of novel medicines using biotechnology techniques. Avecia operates as a contract manufacturing organization (CMO), specializing in oligonucleotide production.[2]
Avecia has two US FDA-audited facilities, one near Boston, MA, and the second in Cincinnati, OH. The combined capacity of these two sites allows Avecia to handle oligonucleotide programs from the pre-clinical through commercial stages. In 2016 Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals.[2]
References
- ↑ http://www.nitto.com www.nitto.com
- 1 2 "Nitto Denko Avecia Inc. Acquires the Businesses of Irvine Pharmaceutical Services & Avrio Biopharmaceuticals". Business Wire. 11 October 2016. Retrieved 8 February 2018.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.